|
|
|
|
|
by dalke
3732 days ago
|
|
Referee wrangling is not unique to Elsevier. While you are correct about "one of the pillars of these publishers' income", I have heard very few argue that referee compensation would improve the situation. To the best of my limited knowledge, the complaints about reviewers taking a long time or not responding at all are independent of the publisher, and equally true for open access journals. I've gotten my share of "the deadline is in two days" emails. No can I think of what compensation might entice me to respond in three days rather than three weeks. The blanket statement "Over here, in the industry" does not universally apply. In my field of pharmaceutical chemistry, I believe most research papers are from industry, they participate in the free peer review model, and do not believe their image has been compromised. Your industry may well be different; perhaps it doesn't have a large research component? |
|
Referee compensation alone? No, not at all. I think compensation would help to some degree, but it wouldn't bring an end to these problems.
What I argue is simply the point that managing editors is a very complex matter that is extremely expensive and somehow justifies what publishers are charging for it. It's certainly not as trivial as just sending e-mails (because of the, uh, human factors), but obviously the bulk of it is done by the reviewers -- and they basically do it for free. If this money, or at least part of it, were to go to the reviewers, the claim would at least be credible. As it stands now, it's simply not.
It's as if I were running a paint shop, charged clients a thousand times the sum of the paint (claiming that I do more than just splat paint on cars -- which would be arguably true), but then paid zero wages to all employees except for a few supervisors (not to mention magically reusing every bucket of paint I ever bought, just to keep the analogy correct). Sure, I'd be doing more than just splattering paint on cars -- but a-thousand-times-the-price-of-the-paint-more, when I'd basically have an endless supply of paint that I'm given more or less for free, and only have to pay like 10% of my employees?
Maybe the scientific publishing business isn't profitable enough to allow for proper remuneration (and defining "proper" is also difficult). But, leaving aside the - possibly idealistic - observation that it's probably important enough that maybe it could be worth doing it for no profit at all (or at least for something somewhat more modest that 2 billion dollars!), that's certainly not an argument for keeping it unfair, too. Surely, some payment, even if meager, would at least provide some peace of mind for some of the reviewers, and is arguably better than no payment at all
> Your industry may well be different; perhaps it doesn't have a large research component?
Hm. I guess my claim about industry isn't entirely fair, seeing how the field in which I did academic work (briefly and at a very basic level) is not quite the same as the one I'm active in (tl;dr a niche in microelectronics back then vs. computer engineering now). In any case, indeed, I think neither of these fields have as large a research component as pharmaceutical chemistry (microelectronics as a whole probably does, but what I was doing wasn't as fancy as the name of the field would imply).